Mine & Arao Wealth Creation & Management’s Moderna MRNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-100
Closed -$12K 336
2022
Q3
$12K Hold
100
0.01% 214
2022
Q2
$14K Hold
100
0.01% 213
2022
Q1
$17K Hold
100
0.01% 208
2021
Q4
$25K Hold
100
0.01% 194
2021
Q3
$38K Hold
100
0.02% 165
2021
Q2
$23K Hold
100
0.01% 191
2021
Q1
$13K Hold
100
0.01% 205
2020
Q4
$10K Hold
100
0.01% 206
2020
Q3
$7K Buy
+100
New +$6.97K 0.01% 210

Other funds holding MRNA

Mine & Arao Wealth Creation & Management's MRNA Position: Q4 2022 in Review

Mine & Arao Wealth Creation & Management sold out of Moderna (MRNA) in Q4 2022, closing a stake of 100 shares — an estimated $12K sold.

Mine & Arao Wealth Creation & Management first reported a position in MRNA in Q3 2020 and held it in 9 quarters. The position peaked at $38K in Q3 2021. 1,071 funds tracked by Wall St. Rank hold MRNA as of Q4 2022.

  • Mine & Arao Wealth Creation & Management reported no remaining Moderna position as of Q4 2022 after selling out during the quarter.
  • Mine & Arao Wealth Creation & Management sold 100 Moderna shares in Q4 2022, an estimated $12K.
  • Mine & Arao Wealth Creation & Management first reported a position in Moderna in Q3 2020 and held it in 9 quarters.
  • Mine & Arao Wealth Creation & Management's Moderna position peaked at $38K in Q3 2021.
  • 1,071 funds tracked by Wall St. Rank held Moderna as of Q4 2022.

Based on Mine & Arao Wealth Creation & Management's 13F filing for Q4 2022, filed 6 Feb 2023.